EUVIMEDEUVIMED entdecken
Crossref

Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designs

Florence Loingeville iD, Manel Rakez, Thu Thuy Nguyen, Mark Donnelly, Lanyan Fang, Kevin Feng, Liang Zhao, Stella Grosser, Guoying Sun, Wanjie Sun, France Mentré, Julie Bertrand

Statistical Methods in Medical Research · 2025

DOI: 10.1177/09622802251354925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2025. Verfasst von Florence Loingeville und 11 weiteren Autor:innen. Beteiligte Einrichtung: ULR 2694 - METRICS : Evaluation of Health Technologies and Medical Practices, University of Lille, CHU Lille, Lille, France. Hauptthemen laut MEDLINE: Models, Statistical, Research Design. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Center for Drug Evaluation and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In pharmacokinetic (PK) bioequivalence (BE) analysis, the recommended approach is the two one-sided tests (TOSTs) on non-compartmental analysis (NCA) estimates of area under the plasma drug concentration versus time curve and C m a x (NCA-TOST). Sample size estimation for a BE study requires assumptions on between/within subject variability (B/WSV). When little prior information is available, interim analysis using two-stage group sequential (GS) or adaptive designs (ADs) may be beneficial. GS fixes the second stage size, while AD requires sample re-estimation based on first-stage results. Recent research has proposed model-based (MB) TOST, using nonlinear mixed effects models, as an alternative to NCA-TOST. This work extends GS and AD approaches to MB-TOST. We evaluated these approaches on simulated parallel and two-way crossover designs for a one-compartment PK model, considering three variability levels for initial sample size calculation. We compared final sample size, type I error, and power estimates from one-stage, GS, and AD designs using NCA-TOST and MB-TOST. Results showed both NCA-TOST and MB-TOST reasonably controlled type I error while maintaining adequate power in two-stage GS and AD approaches, based on our limited computation power. Two-stage designs reduced sample size compared to traditional designs, especially for highly variable drugs, with many trials stopping at Stage 1 in AD designs. Our findings suggest MB-TOST may serve as a viable alternative to NCA-TOST for BE assessment in two-stage designs, especially when B/WSV impacts BE results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, StatisticalResearch DesignTherapeutic EquivalencyCross-Over StudiesHumansSample SizeComputer SimulationArea Under CurvePharmacokinetics

Stichwörter der Autor:innen

Bioequivalencecombination of p-values testnonlinear mixed effects modelsample size re-estimationtwo-one sided testtwo-stage designtype I error control

Autor:innen und Institutionen

  • ULR 2694 - METRICS : Evaluation of Health Technologies and Medical Practices, University of Lille, CHU Lille, Lille, France.
  • Biostatistics team, Bordeaux Population Health, INSERM U1219, Bordeaux, France.
  • Inserm, IAME, Université Paris Cité, Paris, France.
  • Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD USA.
  • Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

ORCID-Profile: Florence Loingeville

Förderung

  • Center for Drug Evaluation and Research

Zitieren

APA

Loingeville, F., Rakez, M., Thuy Nguyen, T., Donnelly, M., Fang, L., Feng, K., Zhao, L., Grosser, S., Sun, G., Sun, W., Mentré, F., & Bertrand, J. (2025). Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designs. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802251354925

Vancouver

Loingeville F, Rakez M, Thuy Nguyen T, Donnelly M, Fang L, Feng K, et al. Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designs. Statistical Methods in Medical Research. 2025. doi:10.1177/09622802251354925

BibTeX
@article{Loingeville2025,
  author = {Loingeville, Florence and Rakez, Manel and Thuy Nguyen, Thu and Donnelly, Mark and Fang, Lanyan and Feng, Kevin and Zhao, Liang and Grosser, Stella and Sun, Guoying and Sun, Wanjie and Mentré, France and Bertrand, Julie},
  title = {Model-based approach for two-stage group sequential or adaptive designs in bioequivalence studies using parallel and crossover designs},
  journal = {Statistical Methods in Medical Research},
  year = {2025},
  doi = {10.1177/09622802251354925}
}
Kostenlos starten →